NCT06008678 - Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea | Biotech Hunter

Enrollment

146

Participants

Timeline

Start Date

August 22, 2023

Primary Completion Date

November 22, 2023

Study Completion Date

November 29, 2023

Conditions

Obstructive Sleep Apnea

Interventions

DEVICE

RXiBreeze PAP System, Model RXiBreeze 20A

The RXiBreeze PAP System is a prescription-only positive airway pressure (PAP) ventilator used to treat obstructive sleep apnea (OSA). It is a microprocessor-controlled device that provides mechanical ventilation to a subject.

Trial Locations (9)

30328

NeuroTrials Research, Atlanta

45240

Intrepid Research, Cincinnati

68510

Somnos Clinical Research, Lincoln

91910

Exalt Clinical Research, Chula Vista

94010

Peninsula Sleep Center, Burlingame

94040

Bay Sleep Clinic, Mountain View

94583

TriValley Sleep Center, San Ramon

96003

Innovative Sleep Centers, Inc., Redding

98510

Innovative Sleep Centers, PLLC, Tumwater